We are almost there ...
Zydus Lifesciences pulled up by FDA over quality-control issues
The US health regulator, in a letter to the pharma company, accuses it of violating good manufacturing practices at its Vadodara plant.
15 September, 2024•2 min
0
15 September, 2024•2 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
Yas Island residential project goes from launch to sold-out in a day
Waldorf Astoria Residences make a splash in Abu Dhabi and the Dubai government is breaking up its properties into pieces.
You may also like
Internet
Why quick delivery of medicines will be difficult to scale
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
Internet
Why is Swiggy catching flak for its latest quick-delivery promise?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
